Diligence memo · auto-generated · as of July 2, 2026
Xhale Innovations, Inc.
Xhale Innovations, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Xhale Innovations, Inc. operates in Biotechnology, based in GAINESVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Xhale Innovations, Inc. has raised $6.5M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $6.5M on —.
Valuation (modeled)modeled
Provath models Xhale Innovations, Inc. at approximately $13M (range $7.1M–$18M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.14× the median modeled value of Series A Biotechnology companies (1090 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
Comparablesmixed
Capital scale ranks ahead of 48% of Biotechnology peers (4293 compared).
Modeled value ranks above 22% of those peers.
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.